Jon P. Weber

Array ( [id] => 4355773 [patent_doc_number] => 06190875 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe' [patent_app_type] => 1 [patent_app_number] => 9/113168 [patent_app_country] => US [patent_app_date] => 1998-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 17 [patent_no_of_words] => 15546 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/190/06190875.pdf [firstpage_image] =>[orig_patent_app_number] => 113168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4285864 [patent_doc_number] => 06268197 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Xyloglucan-specific alkaline xyloglucanase from bacillus' [patent_app_type] => 1 [patent_app_number] => 9/110959 [patent_app_country] => US [patent_app_date] => 1998-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24270 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268197.pdf [firstpage_image] =>[orig_patent_app_number] => 110959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4327828 [patent_doc_number] => 06312919 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Process for producing a cholesterol-reduced substance' [patent_app_type] => 1 [patent_app_number] => 9/101327 [patent_app_country] => US [patent_app_date] => 1998-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14234 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/312/06312919.pdf [firstpage_image] =>[orig_patent_app_number] => 101327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4096992 [patent_doc_number] => 06099836 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Platelet-activating factor acetylhydrolase (PAF-AH) therapeutic uses' [patent_app_type] => 1 [patent_app_number] => 9/100546 [patent_app_country] => US [patent_app_date] => 1998-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 33053 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/099/06099836.pdf [firstpage_image] =>[orig_patent_app_number] => 100546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4070178 [patent_doc_number] => 06069009 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-30 [patent_title] => 'Method for increasing the growth of plant cell cultures' [patent_app_type] => 1 [patent_app_number] => 9/099578 [patent_app_country] => US [patent_app_date] => 1998-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 4888 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/069/06069009.pdf [firstpage_image] =>[orig_patent_app_number] => 099578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4184857 [patent_doc_number] => 06093557 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'Electrospraying apparatus and method for introducing material into cells' [patent_app_type] => 1 [patent_app_number] => 9/092794 [patent_app_country] => US [patent_app_date] => 1998-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 13975 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093557.pdf [firstpage_image] =>[orig_patent_app_number] => 092794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4112599 [patent_doc_number] => 06071514 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Methods for treating thrombotic disorders' [patent_app_type] => 1 [patent_app_number] => 9/090061 [patent_app_country] => US [patent_app_date] => 1998-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4812 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071514.pdf [firstpage_image] =>[orig_patent_app_number] => 090061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4088964 [patent_doc_number] => 06133231 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Angiogenesis using hepatocyte growth factor' [patent_app_type] => 1 [patent_app_number] => 9/086498 [patent_app_country] => US [patent_app_date] => 1998-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3562 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133231.pdf [firstpage_image] =>[orig_patent_app_number] => 086498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4154987 [patent_doc_number] => 06156557 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Alkaline protease from streptomyces sp. and method for preparing the same' [patent_app_type] => 1 [patent_app_number] => 9/076842 [patent_app_country] => US [patent_app_date] => 1998-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4805 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 242 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156557.pdf [firstpage_image] =>[orig_patent_app_number] => 076842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237119 [patent_doc_number] => 06080564 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Selective inactivation of Aspergillus proteases' [patent_app_type] => 1 [patent_app_number] => 9/076460 [patent_app_country] => US [patent_app_date] => 1998-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5330 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080564.pdf [firstpage_image] =>[orig_patent_app_number] => 076460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4059480 [patent_doc_number] => 06007810 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Chondroitinase compositions' [patent_app_type] => 1 [patent_app_number] => 9/070763 [patent_app_country] => US [patent_app_date] => 1998-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8031 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/007/06007810.pdf [firstpage_image] =>[orig_patent_app_number] => 070763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3938561 [patent_doc_number] => 05997895 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Dural/meningeal repair product using collagen matrix' [patent_app_type] => 1 [patent_app_number] => 9/070659 [patent_app_country] => US [patent_app_date] => 1998-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6976 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/997/05997895.pdf [firstpage_image] =>[orig_patent_app_number] => 070659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4177780 [patent_doc_number] => 06159468 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Activated protein C formulations' [patent_app_type] => 1 [patent_app_number] => 9/065975 [patent_app_country] => US [patent_app_date] => 1998-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5569 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159468.pdf [firstpage_image] =>[orig_patent_app_number] => 065975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4083033 [patent_doc_number] => 06162629 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Methods for processing activated protein C' [patent_app_type] => 1 [patent_app_number] => 9/065872 [patent_app_country] => US [patent_app_date] => 1998-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5224 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162629.pdf [firstpage_image] =>[orig_patent_app_number] => 065872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3994034 [patent_doc_number] => 05919775 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Method for inhibiting expression of inducible nitric oxide synthase with tetracycline' [patent_app_type] => 1 [patent_app_number] => 9/061286 [patent_app_country] => US [patent_app_date] => 1998-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 11060 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919775.pdf [firstpage_image] =>[orig_patent_app_number] => 061286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4126616 [patent_doc_number] => 06127338 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes' [patent_app_type] => 1 [patent_app_number] => 9/053617 [patent_app_country] => US [patent_app_date] => 1998-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 19 [patent_no_of_words] => 6058 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127338.pdf [firstpage_image] =>[orig_patent_app_number] => 053617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4268892 [patent_doc_number] => 06245566 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Human embryonic germ cell line and methods of use' [patent_app_type] => 1 [patent_app_number] => 9/052772 [patent_app_country] => US [patent_app_date] => 1998-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 10 [patent_no_of_words] => 16295 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245566.pdf [firstpage_image] =>[orig_patent_app_number] => 052772 [rel_patent_id] =>[rel_patent_doc_number] =>)